SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 116 filers reported holding SANA BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $181,213 | -35.1% | 46,825 | 0.0% | 0.02% | -22.7% |
| Q2 2023 | $279,077 | +82.3% | 46,825 | 0.0% | 0.02% | +69.2% |
| Q1 2023 | $153,118 | +82666.5% | 46,825 | 0.0% | 0.01% | -23.5% |
| Q4 2022 | $185 | -99.8% | 46,825 | +274.6% | 0.02% | +142.9% |
| Q3 2022 | $75,000 | -6.2% | 12,500 | 0.0% | 0.01% | -12.5% |
| Q2 2022 | $80,000 | -58.8% | 12,500 | 0.0% | 0.01% | -46.7% |
| Q1 2022 | $194,000 | 0.0% | 12,500 | 0.0% | 0.02% | 0.0% |
| Q4 2021 | $194,000 | -31.2% | 12,500 | 0.0% | 0.02% | -40.0% |
| Q3 2021 | $282,000 | +14.6% | 12,500 | 0.0% | 0.02% | +13.6% |
| Q2 2021 | $246,000 | – | 12,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 34,239,018 | $673,139,000 | 8.60% |
| Trustees of Columbia University in the City of New York | 281,250 | $5,530,000 | 8.17% |
| Crestline Management, LP | 3,210,937 | $63,127,000 | 5.44% |
| Omega Fund Management, LLC | 843,750 | $16,588,000 | 1.88% |
| Alphabet Inc. | 2,812,500 | $55,294,000 | 1.13% |
| SB Management Ltd | 2,625,153 | $51,611,000 | 0.61% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 4,508,111 | $88,629,000 | 0.53% |
| HARVARD MANAGEMENT CO INC | 468,749 | $9,216,000 | 0.53% |
| Avidity Partners Management LP | 778,597 | $15,307,000 | 0.41% |
| Dragoneer Investment Group | 1,500,000 | $29,490,000 | 0.38% |